Our advocacy for federal guidelines related to gender-diverse (transgender, non-binary, gender non-conforming, and other non-cisgender identities) blood donors are included here. To read our research brief submitted to the FDA, click here.
This content will be compiled into a public version of our research brief following dissemination of The Breakdown
Resources for those transitioning will be shared following the completion of the Public Brief
This content will be compiled into a public version of our research brief following dissemination of The Breakdown
Resources for those transitioning will be shared following the completion of the Public Brief
Overview - Blood Donation - Blood Products - Sex/Gender/Gender-Diversity - Transitioning - Legal Recognition - Hemoglobin - Current Practices - FDA Language - Pregnancy - the Immune System - the Respiratory System - TRALIs - Transfusion Mortality - Governing Bodies - Reccomendations
*Topics not in bold are currently being researched and prepared for release*
*Topics not in bold are currently being researched and prepared for release*
Overview
|
|
|
Blood Donation
|
Blood Products
|
|
|
Sex, Gender & Gender-Diversity
|
Transitioning
|
|
|
Legal Recognition
|
Hemoglobin
|
|